ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference., and the leading global conference for health economics a
This randomized clinical trial assesses the effect of adding panitumumab vs bevacizumab to standard first-line chemotherapy on overall survival among patients w